The French Government has published a list of some drugs that are no longer eligible for reimbursement by the French Government from the very first day of the upcoming year. The list includes homeopathic and herbal medicines, there are no confirmations for allopathic drugs yet.
The list has been confirmed by the Health minister Agnès Buzyn confirmed the list this week, following her decision in the initial stage of this year to separate out State reimbursements of homeopathic and herbal medicines. The decision was made in July this year after health authority la Haute Autorité de Santé concluded that the products lacked in the efficiency according to a data available. As a result, the amount of reimbursement provided by the state for homeopathic medicine will drop from its current level of 30% to 15% from January 1, 2020, and to 0% from January 1, 2021.
The decision taken by Ms. Buzyn turned out controversial and has been criticized by a group of pro-homeopathy French MPs, as well as major homeopathic medicine producers and French company Laboratoires Boiron. Boiron launched a campaign called “Mon Homéo Mon Choix (My Homeopathy, My Choice)” with homeopathy teaching authority CEDH. Yet, in an interview, Ms. Buzyn said: “I understand the attachment that the French people have for this type of treatment, but homeopathy has not proven their benefit to public health, not even to the current pathologies. We probably should focus more on the idea that it is not always necessary to take medicine.”